EARLI Trademark

Trademark Overview


On Friday, January 27, 2023, a trademark application was filed for EARLI with the United States Patent and Trademark Office. The USPTO has given the EARLI trademark a serial number of 97770271. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 15, 2024. This trademark is owned by Earli Inc. The EARLI trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Medical Instrument Products categories with the following description:

Scientific apparatus in the nature of medical laboratory research instruments for the detection and localization of diseases, pathogens and toxins in a biological sample obtained from humans and animals for research use

Pharmaceutical and veterinary preparations and products for medical purposes for the prevention, detection, localization, and treatment of infectious viral-based, diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, and toxins in the body tissue and fluids of humans and animals; Drug delivery agents in the form of tablet coatings, edible wafers, powders, tablets, and capsules that facilitate the delivery of other pharmaceutical preparations into human and animal bodies; Reagents for use in therapeutics for medical purposes; Diagnostic and therapeutic preparations for medical purposes, namely, diagnostic preparations and therapeutic pharmaceutical preparatio...

Medical devices for delivering pharmaceutical preparations and genetic material into human or animal tissues and cells for the purpose of diagnosis of disease or treatment of disease, pathogens, and toxins in humans and animals, namely, syringes, implantable drug delivery pumps with and without catheters, infusion pumps, drug delivery catheters, infusion sets, cannulas, transdermal drug delivery patches, autoinjectors being injection devices for administering drugs, electroporators being electromagnetic drug delivery apparatus for medical use, and inhaled delivery devices being inhalers for medical purposes, all the forgoing sold empty and without medication; Medical devices for the delivery of pharmaceutical preparations and genetic material into human or animal tissues and cells for the purpose of diagnosis of disease or treatment of disease, pathogens, and toxins in humans and animals, namely, inhalers for medical purposes, sold empty and drug delivery patches sold without medicatio...
earli

General Information


Serial Number97770271
Word MarkEARLI
Filing DateFriday, January 27, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements


Goods and ServicesScientific apparatus in the nature of medical laboratory research instruments for the detection and localization of diseases, pathogens and toxins in a biological sample obtained from humans and animals for research use
Goods and ServicesPharmaceutical and veterinary preparations and products for medical purposes for the prevention, detection, localization, and treatment of infectious viral-based, diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, and toxins in the body tissue and fluids of humans and animals; Drug delivery agents in the form of tablet coatings, edible wafers, powders, tablets, and capsules that facilitate the delivery of other pharmaceutical preparations into human and animal bodies; Reagents for use in therapeutics for medical purposes; Diagnostic and therapeutic preparations for medical purposes, namely, diagnostic preparations and therapeutic pharmaceutical preparations for detecting and treating infectious viral-based diseases, infectious bacterial-based diseases, infectious fungal based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, and gastrointestinal diseases and conditions, and for detecting the presence of toxins in body tissue and fluids; medical diagnostic reagents and assays for testing of body fluids, reagents for medical use, diagnostic reagents for medical uses, enzymes for medical purposes, and diagnostic nucleotides for medical use; medical diagnostic assays for testing of body fluids, biological preparations in the nature of recombinant nucleic acid vectors, biological preparations in the nature of recombinant viral vectors, transfection agents being reagents for medical use, reagents for medical use, enzymes for medical purposes, and diagnostic nucleotides for medical purposes, and diagnostic nucleotides for medical use, all for the foregoing being for the treatment of infectious viral-based, diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, and toxins in the body tissue and fluids of humans and animals; medical diagnostic assays and reagents for testing of body fluids, reagents for medical use, enzymes for medical purposes, and diagnostic nucleotides for medical use, all the forgoing for medical diagnostic and treatment purposes, namely, for use in detecting and treating infectious viral-based diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, and gastrointestinal diseases and conditions, and for use in detecting the presence of toxins in body tissue and fluids and for eliminating toxins from body tissue and fluids; therapeutic diagnostic agents for medical purposes, therapeutic agents in the nature of therapeutic pharmaceuticals for the treatment of cancer, infectious viral-based diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, respiratory diseases, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, liver and pancreatic diseases, muscular and neuromuscular diseases, and gastrointestinal diseases and conditions, and therapeutic agents being therapeutic diagnostic and pharmaceutical preparations for detecting the presence of toxins in body tissue and fluid and for eliminating toxins from body tissue and fluids; therapeutic agents for medical diagnostic purposes and treatment purposes, namely, biological preparation in the nature of viral vectors and non-viral transfection agents being reagents for medical use based on linear or branched polyethyleneimines, nano-particles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, that facilitate the delivery of a wide range of pharmaceuticals or nucleic acid sequences into human and animal bodies to detect and treat infectious viral-based diseases, infectious bacterial-based diseases, infectious fungal-based diseases, autoimmune diseases, allergies, heart- and vascular-based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood-based diseases, kidney diseases, pancreatic diseases, muscular and neuromuscular diseases, and gastrointestinal diseases and conditions, and for eliminating toxins in body tissue and fluids
Goods and ServicesMedical devices for delivering pharmaceutical preparations and genetic material into human or animal tissues and cells for the purpose of diagnosis of disease or treatment of disease, pathogens, and toxins in humans and animals, namely, syringes, implantable drug delivery pumps with and without catheters, infusion pumps, drug delivery catheters, infusion sets, cannulas, transdermal drug delivery patches, autoinjectors being injection devices for administering drugs, electroporators being electromagnetic drug delivery apparatus for medical use, and inhaled delivery devices being inhalers for medical purposes, all the forgoing sold empty and without medication; Medical devices for the delivery of pharmaceutical preparations and genetic material into human or animal tissues and cells for the purpose of diagnosis of disease or treatment of disease, pathogens, and toxins in humans and animals, namely, inhalers for medical purposes, sold empty and drug delivery patches sold without medication; Medical instruments for use in treating infectious diseases and for eliminating pathogens and toxins in humans and animals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2023
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEarli Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 94022

Party NameEarli Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94022

Trademark Events


Event DateEvent Description
Tuesday, January 31, 2023NEW APPLICATION ENTERED
Wednesday, February 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 26, 2023ASSIGNED TO EXAMINER
Thursday, November 2, 2023PRIORITY ACTION WRITTEN
Thursday, November 2, 2023PRIORITY ACTION E-MAILED
Thursday, November 2, 2023NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, January 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 16, 2024FINAL REFUSAL WRITTEN
Friday, February 16, 2024FINAL REFUSAL E-MAILED
Friday, February 16, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, May 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 15, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 14, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED